the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Ringgit improves against US dollar ahead of OPR announcement

KUALA LUMPUR: The ringgit closed higher against the US dollar and a basket of other major currencies as well as Asean currencies ahead of Bank Negara Malaysia’s (BNM) decision on the overnight policy rate (OPR) on March 7.

At 6 pm, the ringgit improved to 4.7200/7250 against the greenback compared with Friday’s close of 4.7440/7480.

Bank Muamalat Malaysia Bhd chief economist Mohd Afzanizam Abdul Rashid said most economists are expecting the OPR to stand pat at 3.00 per cent.

“This week is quite an important week as the US Federal Reserve chairman will also share its latest economic assessment with Congress on March 7,“ he told Bernama.

In addition, investors await the US Nonfarm Payroll (NFP) on Friday.

Hence, Mohd Afzanizam expects the currency market to remain guarded in the near future as uncertainties over the first US interest rate cut will continue to dominate market sentiments.

“Not to mention, China’s National People’s Congress (NPC) will also be closely monitored as investors will scrutinise the macro targets in the search for clues of economic stimulus,“ he said.

Back home, the ringgit was traded higher against a basket of major currencies.

The local currency rose against the British pound to 5.9840/9904 from 5.9926/9977 last Friday, strengthened versus the euro to 5.1198/1252 from 5.1330/1373 last week, and improved vis-a-vis the Japanese yen to 3.1410/1445 from 3.1492/1521 previously.

At the same time, the ringgit traded higher against other Asean currencies.

It was higher versus the Thai baht at 13.1766/1965 from Friday’s close of 3.1928/2120 and gained against the Singapore dollar to 3.5137/5177 compared to 3.5229/5264 last week.

The ringgit also firmed vis-a-vis the Indonesian rupiah to 299.7/300.2 from 302.1/302.4 and inched up against the Philippine peso at 8.43/8.44 from 8.47/8.48 previously. –Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings